Using small molecules to boost lubricin for treating post-traumatic osteoarthritis
Small molecule stimulation of lubricin for treatment of post-traumatic osteoarthritis
This study is looking at how certain approved medications can help boost the production of a protective protein called lubricin in people with post-traumatic osteoarthritis, with the hope of finding new ways to improve joint health after knee injuries.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Central Florida NIH-funded |
| Lab location | 1 site (Orlando, United States) |
| Project ID | NIH-10888514 on NIH RePORTER |
What this research studies
This research investigates how small molecules can stimulate the production of lubricin, a protein that helps protect cartilage, in patients suffering from post-traumatic osteoarthritis (PTOA). The approach involves screening FDA-approved drugs using specially engineered human cells that produce a measurable signal when lubricin is stimulated. By simulating knee injuries in a lab setting, researchers will identify effective compounds that enhance lubricin expression, potentially leading to new treatments for PTOA. The goal is to find a pharmacological solution that could modify the disease process and improve joint health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced knee injuries, such as anterior cruciate ligament (ACL) tears, and are at risk of developing post-traumatic osteoarthritis.
Not a fit: Patients who do not have a history of knee injuries or those with other forms of osteoarthritis unrelated to trauma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve joint function and reduce pain for patients with post-traumatic osteoarthritis.
How similar studies have performed: While the approach of stimulating lubricin production is innovative, similar strategies targeting cartilage health have shown promise in other studies, suggesting potential for success.
Where this research is happening
Orlando, United States
- University of Central Florida — Orlando, United States (Active)
Researchers
- Principal investigator: Kean, Thomas J. — University of Central Florida
- Study coordinator: Kean, Thomas J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.